Summary
Novo Nordisk and Eli Lilly have dominated the market until now, but this year is set to bring oral drugs, generics, and a fight for global dominance.
Source: livemint.com
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
